Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -94.21%3K | -90.82%5.64K | -62.46%31.05K | -91.27%8.06K | -91.27%8.06K | -48.70%51.7K | 69.32%61.38K | 40.45%82.72K | -10.44%92.33K | --92.33K |
| -Cash and cash equivalents | -94.21%3K | -90.82%5.64K | -62.46%31.05K | -91.27%8.06K | -91.27%8.06K | -48.70%51.7K | 69.32%61.38K | 40.45%82.72K | -10.44%92.33K | --92.33K |
| Current deferred assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Total current assets | -94.21%3K | -90.82%5.64K | -62.46%31.05K | -91.27%8.06K | -91.27%8.06K | -48.70%51.7K | 32.71%61.38K | 20.07%82.72K | -18.36%92.33K | --92.33K |
| Non current assets | ||||||||||
| Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | -94.21%3K | -90.82%5.64K | -62.46%31.05K | -91.27%8.06K | -91.27%8.06K | -48.70%51.7K | 32.71%61.38K | 20.07%82.72K | -18.36%92.33K | --92.33K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current debt and capital lease obligation | --30K | --30K | --30K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Current debt | --30K | --30K | --30K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Payables | ---- | ---- | ---- | ---- | ---- | --29.01K | ---- | ---- | ---- | ---- |
| -accounts payable | ---- | ---- | ---- | ---- | ---- | --29.01K | ---- | ---- | ---- | ---- |
| Current liabilities | 47.39%42.76K | 623.98%34.05K | 157.60%55.39K | 37.23%21.39K | 37.23%21.39K | 1,000.99%29.01K | -93.92%4.7K | -70.09%21.5K | -82.18%15.59K | --15.59K |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | 47.39%42.76K | 623.98%34.05K | 157.60%55.39K | 37.23%21.39K | 37.23%21.39K | 1,000.99%29.01K | -93.92%4.7K | -70.09%21.5K | -82.18%15.59K | --15.59K |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%246.75K | 0.00%246.75K | 0.00%246.75K | 0.00%246.75K | 0.00%246.75K | 0.00%246.75K | 114.36%246.75K | 114.36%246.75K | 114.36%246.75K | --246.75K |
| -common stock | 0.00%246.75K | 0.00%246.75K | 0.00%246.75K | 0.00%246.75K | 0.00%246.75K | 0.00%246.75K | 114.36%246.75K | 114.36%246.75K | 114.36%246.75K | --246.75K |
| Retained earnings | -24.39%-318.51K | -38.32%-307.16K | -39.33%-303.08K | -44.59%-292.08K | -44.59%-292.08K | -41.78%-256.05K | -51.87%-222.07K | -84.17%-217.53K | -125.75%-202K | ---202K |
| Gains losses not affecting retained earnings | 0.00%32K | 0.00%32K | 0.00%32K | 0.00%32K | 0.00%32K | 0.00%32K | --32K | --32K | --32K | --32K |
| Total stockholders'equity | -275.23%-39.77K | -150.13%-28.41K | -139.75%-24.34K | -117.37%-13.33K | -117.37%-13.33K | -76.88%22.69K | 282.13%56.68K | 2,137.75%61.21K | 199.44%76.74K | --76.74K |
| Total equity | -275.23%-39.77K | -150.13%-28.41K | -139.75%-24.34K | -117.37%-13.33K | -117.37%-13.33K | -76.88%22.69K | 282.13%56.68K | 2,137.75%61.21K | 199.44%76.74K | --76.74K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.